Skip to content

Clinical trials

Completed Phase 2 Leukemia, Promyelocytic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Promyelocytic, Acute Phase: Phase 2 Status: Completed Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20031
20042
20063
20074
20112
20131

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
National Cancer Institute (NCI)5
Case Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
Northwestern University2
Alliance for Clinical Trials in Oncology1
Barbara Ann Karmanos Cancer Institute1
CytRx1
Eastern Cooperative Oncology Group1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Promyelocytic, Acute25
Leukemia, Myeloid, Acute16
Leukemia14
Leukemia, Myelomonocytic, Acute13
Leukemia, Erythroblastic, Acute9
Leukemia, Monocytic, Acute9
Myelodysplastic Syndromes9
Leukemia, Megakaryoblastic, Acute8
Congenital Abnormalities7
Leukemia, Lymphocytic, Chronic, B-Cell5

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.